HIMS — Put-Selling Research

by ThetaLoop Research
Skip to content
← Back to search
Last close:
Hims & Hers Health, Inc.
Healthcare · $26.19
1.0
/10
Poor Entry
Put-selling entry timing — not a quality rating.A strong long-term holding can still show a low score today (thin premium, extended trend, or turning momentum).
How this score works → Try the calculator ↓
Regime
Bearish
vs SMA200
SMA200 Distance
-22.9%
Below trend
Volatility
Normal
Average premiums
Momentum
Positive
3rd day
About Hims & Hers Health, Inc.
Telehealth and DTC wellness platform offering GLP-1 access, skincare, and hair loss treatments. No dividend, high beta, sentiment-driven. Regulatory headlines create constant catalysts. Rich premiums but news risk cuts both ways — not for autopilot sellers.
Drug Manufacturers - Specialty & Generic
Market Cap
$6.1B
P/E Ratio
Beta
2.40
Forward P/E
20.4
52-Week Range Current: $26.19
$13.74 $70.43
Earnings
2026-08-10
65 days away

HIMS — price 22.9% below the long-term average is the dominant feature today. Extensions of this magnitude historically resolve toward the average over weeks, regardless of what the composite reads in the meantime.

Based on end-of-day market dataScored by ThetaLoop Research
HIMS ranks #22 of 66 Healthcare tickers by put-selling score (622 total screened)

Position Size & Yield Calculator

Live model for HIMS — drag any slider to recalculate. Strike defaults to ~5% OTM, snapped to typical exchange increments.
$
$
$
days
0
max fully-secured contracts
Capital per Contract0%
$0
Premium Income
$0
per contract
Per-Day Theta
$0.00
if held to expiration
Annualized ROC
0.0%
return on collateral
📈At this pace: $0/year per contract if you roll continuously every 30 days
Calculator assumptions

Cash-secured puts require holding cash equal to strike × 100 shares as collateral. Strike defaults to ~5% OTM, snapped to typical exchange increments. Premium defaults to ~2% of strike — adjust to your real expected fill. Annualized ROC = (premium ÷ collateral) × (365 ÷ DTE). CSP risk is single-name concentration: experienced put-sellers typically diversify across 4–6 underlyings rather than committing the whole account to one ticker. Continuous-rolling projections assume capital can be re-deployed after each expiration and that comparable premiums remain available — actual results vary with market conditions, assignments, and rolls.

This page is the research tool — you search any ticker, get the score, configure your own setup. The daily research publishes setups that pass the nightly filters, with strike, expiry, profit-capture references, and a tracking framework. Not every ticker, not every day. Quiet days are quiet. See a sample · how the pipeline works
More Healthcare Research
GILD Gilead Sciences, Inc. 6.7 BMY Bristol-Myers Squibb Company 6.2 REGN Regeneron Pharmaceuticals, Inc. 6.1 PFE Pfizer Inc. 6.0 BHC Bausch Health Companies Inc. 4.7 Browse all Healthcare tickers →
📌 Embed this score on your blog
The HIMS X-Ray score updates daily after market close. Embed it on any site, blog, or trading journal — completely free, no API key needed. The visible attribution line below the widget links back to ThetaLoop and helps the project grow.
<iframe src="https://thetaloop.app/widget/xray/HIMS" width="400" height="460" frameborder="0" loading="lazy"></iframe> <p style="text-align:center;font-size:11px;margin-top:6px;font-family:sans-serif"><a href="https://thetaloop.app/xray/HIMS">HIMS X-Ray Score</a> by ThetaLoop</p>
Live preview: Open widget in new tab →
When setups pass our filters, see the full research format. See how daily research works →
📊 Full Research Track Record — All Wins AND Losses
Cash-Secured Puts ↗ · Bull Put Spreads ↗ · See a sample →